Nicotine and Chronic Kidney Disease
尼古丁与慢性肾脏病
基本信息
- 批准号:7524184
- 负责人:
- 金额:$ 56.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-20 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAngiotensin IIAnimal ModelAnimalsArtsAtherosclerosisBiological AssayBlood VesselsCell ProliferationChronic Kidney FailureClinicalClinical ResearchCollagen Type IVCyclinsDahl Hypertensive RatsDataDepositionDiabetes MellitusDialysis procedureEnd stage renal failureExtracellular MatrixExtracellular Matrix ProteinsFibronectinsGoalsGrowthHumanHypertensionImmunohistochemistryIn VitroIncidenceIndividualInjuryKidneyLung diseasesMediatingMediator of activation proteinModelingMolecular BiologyMolecular Biology TechniquesMorbidity - disease rateNational Health and Nutrition Examination SurveyNeuraxisNicotineOutcomePathogenesisPathway interactionsPatientsPlayPopulationPrevalencePreventiveProcessProductionPropertyProstaglandin-Endoperoxide SynthaseProstaglandinsProteinuriaPublic HealthPulmonary HypertensionReactive Oxygen SpeciesRenal glomerular diseaseResearchRiskRisk FactorsRoleSignal TransductionSmokeSmokerSourceTechniquesTestingTherapeuticTissuesTobaccoUnited StatesVascular EndotheliumVascular Smooth MuscleWorkbasecancer typecardiovascular risk factorcell growthcigarette smokingcigarette smokingcostcyclooxygenase 2diabeticexperiencehemodynamicsin vivolung vascular injurymesangial cellmortalitynon-diabeticnovel strategiespreventpublic health relevancereceptorresponsesalt sensitivevasculogenesis
项目摘要
DESCRIPTION (provided by applicant): Cigarette smoking has been identified as the most important cause of preventable morbidity and mortality in the U.S. Recent clinical studies suggest that in addition to being an important cardiovascular risk, cigarette smoking is also an important risk for the progression of chronic kidney disease (CKD) in diabetics, hypertensives and patients with glomerular diseases. The mechanisms by which cigarette smoking promotes the progression of chronic kidney disease have not been elucidated. Nicotine has been proposed as a compound in cigarette smoke that may play a role in the pathogenesis of vascular and lung injury in smokers. We herein hypothesize that nicotine, a stable product present in large amounts in cigarette smoke, accelerates the progression of CKD by promoting mesangial cell proliferation and extracellular matrix (ECM) deposition via specific nicotine receptors and resulting in the activation of pathways involved in cell growth and injury. We will test this hypothesis by pursuing the following specific Aim 1: To identify the role of nicotine exposure as a risk factor in the progression of chronic kidney disease. The hypothesis for this aim is that nicotine accelerates the progression of CKD in animal model of salt sensitive hypertension that is associated with renal injury by increasing the deposition of ECM proteins such as fibronectin and type IV collagen. We will also determine the role of nicotine induced hemodynamic changes on these effects and the distribution and expression of nicotine receptors in the kidneys of these animals. We will use a comprehensive approach utilizing several pharmacologic blockers to assess the effects of nicotine on renal injury in a well validated model of salt sensitive hypertension; Aim 2: To identify the role of ROS and COX-2 derived prostaglandins on the effects of nicotine in renal injury. The hypothesis for this aim that reactive oxygen species (ROS) and COX-2 derived prostaglandins are important mediators of the effects of nicotine induced renal injury in salt sensitive hypertension. These studies will be performed in Dahl salt sensitive rats and utilizing a combination of bioassays, molecular biology and immunohistochemistry techniques to assess the role of COX-2 derived prostaglandins and ROS on nicotine induced renal injury; Aim 3: To establish the signal transduction mechanisms mediating cell proliferation and ECM deposition in response to nicotine. The hypothesis for this aim is that nicotine activates several pathways involved in cell proliferation and matrix production including PKC activation, CREs, and Src/Raf-1/MAPK/cyclins. These studies will be performed in human mesangial cells utilizing a combination of state of the art molecular biology techniques. PUBLIC HEALTH RELEVANCE These studies will determine the role of nicotine as a risk factor in the progression of chronic kidney disease and will identify the mechanisms involved. These studies will unveil mechanisms that may explain the deleterious effects of cigarette smoking on renal injury. These studies will determine the role of nicotine, an important component of cigarette smoke, on kidney damage in an animal model of high blood pressure that is accompanied by kidney injury. We will use a variety of state of the art techniques to assess the mechanisms by which nicotine induces renal injury.
描述(由申请人提供):在美国,吸烟已被确定为可预防发病率和死亡率的最重要原因,这表明,除了是重要的心血管风险外,吸烟还成为糖尿病患者和肾小球疾病患者的慢性肾脏病(CKD)进展的重要风险。吸烟促进慢性肾脏疾病进展的机制尚未阐明。尼古丁已被提议作为香烟烟雾中的化合物,可能在吸烟者的血管和肺损伤的发病机理中起作用。我们在这里假设尼古丁是一种稳定的烟烟,在香烟烟雾中以大量烟雾存在,可以通过特定的尼古丁受体促进肾小球细胞增殖和细胞外基质(ECM)沉积来加速CKD的进展,并导致涉及细胞生长和损伤的途径激活。我们将通过追求以下特定目的1:确定尼古丁暴露是慢性肾脏疾病进展中的危险因素的作用来检验这一假设。该目标的假设是,尼古丁在盐敏感高血压动物模型中加速了CKD的进展,这通过增加ECM蛋白(例如纤连蛋白质和IV型胶原蛋白)的沉积而与肾损伤相关。我们还将确定尼古丁引起的血液动力学变化对这些作用的作用以及尼古丁受体在这些动物肾脏中的分布和表达。我们将利用几种药理阻滞剂使用一种全面的方法来评估尼古丁对盐敏感高血压模型的肾脏损伤的影响;目标2:确定ROS和COX-2衍生的前列腺素对尼古丁在肾损伤中的影响的作用。该目标的假设是,活性氧(ROS)和COX-2衍生的前列腺素是尼古丁诱导的肾脏损伤在盐敏感高血压中的影响的重要介体。这些研究将在DAHL盐敏感大鼠中进行,并利用生物测定,分子生物学和免疫组织化学技术的结合,以评估Cox-2衍生的前列腺素和ROS在尼古丁诱导的肾损伤方面的作用;目标3:建立介导细胞增殖和ECM沉积的信号转导机制,以响应尼古丁。该目标的假设是尼古丁激活了与细胞增殖和基质产生有关的几种途径,包括PKC激活,CRE和SRC/RAF-1/MAPK/Cyclins。这些研究将在人类的细胞细胞中,利用艺术分子生物学技术的结合。公共卫生相关性这些研究将决定尼古丁作为慢性肾脏疾病进展的危险因素的作用,并将确定所涉及的机制。这些研究将揭示可能解释吸烟对肾脏损伤的有害影响的机制。这些研究将确定尼古丁是香烟烟雾的重要组成部分,在伴有肾脏损伤的高血压动物模型中肾脏损伤。我们将使用各种最先进的技术来评估尼古丁诱导肾脏损伤的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDGAR A JAIMES其他文献
EDGAR A JAIMES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDGAR A JAIMES', 18)}}的其他基金
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
纳米技术作为动静脉瘘成熟的治疗方法
- 批准号:
10275814 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
纳米技术作为动静脉瘘成熟的治疗方法
- 批准号:
10666430 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
纳米技术作为动静脉瘘成熟的治疗方法
- 批准号:
10418812 - 财政年份:2021
- 资助金额:
$ 56.74万 - 项目类别:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
ETS-1 与盐敏感性高血压中的血管和肾脏损伤
- 批准号:
8391638 - 财政年份:2010
- 资助金额:
$ 56.74万 - 项目类别:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
ETS-1 与盐敏感性高血压中的血管和肾脏损伤
- 批准号:
8045940 - 财政年份:2010
- 资助金额:
$ 56.74万 - 项目类别:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
ETS-1 与盐敏感性高血压中的血管和肾脏损伤
- 批准号:
8198371 - 财政年份:2010
- 资助金额:
$ 56.74万 - 项目类别:
Glomerular COX-2 in Hypertensive Renal Disease
高血压肾病中的肾小球 COX-2
- 批准号:
7124216 - 财政年份:2005
- 资助金额:
$ 56.74万 - 项目类别:
Glomerular COX-2 in Hypertensive Renal Disease
高血压肾病中的肾小球 COX-2
- 批准号:
6984366 - 财政年份:2005
- 资助金额:
$ 56.74万 - 项目类别:
Glomerular COX-2 in Hypertensive Renal Disease
高血压肾病中的肾小球 COX-2
- 批准号:
7285217 - 财政年份:2005
- 资助金额:
$ 56.74万 - 项目类别:
相似国自然基金
血管紧张素II活化的钙振荡在TBI后PSH相关的神经功能损害中的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PKCε-Rab11介导KCNQ1通道膜蛋白下调促进血管紧张素II诱导的心肌肥厚致心律失常的机制研究
- 批准号:82204397
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血管紧张素II活化的钙振荡在TBI后PSH相关的神经功能损害中的作用与机制研究
- 批准号:82201519
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
血管紧张素II2型受体在血管损伤中抑制周围脂肪组织功能失调的作用及机制研究
- 批准号:82200458
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
血管紧张素II2型受体在血管损伤中抑制周围脂肪组织功能失调的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 56.74万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 56.74万 - 项目类别:
Antihypertensive Effect of Food-Origin Isothiocyanate Soluble Epoxide Hydrolase Inhibitors
食品源异硫氰酸酯可溶性环氧化物水解酶抑制剂的抗高血压作用
- 批准号:
10411131 - 财政年份:2022
- 资助金额:
$ 56.74万 - 项目类别:
The Role of Nrf2 in Proteinuric Chronic Kidney Disease
Nrf2 在蛋白尿性慢性肾病中的作用
- 批准号:
10646177 - 财政年份:2022
- 资助金额:
$ 56.74万 - 项目类别:
Systems Pharmacology Model of Cardiac Hypertrophy
心脏肥大的系统药理学模型
- 批准号:
10598591 - 财政年份:2022
- 资助金额:
$ 56.74万 - 项目类别: